Attempts to treat Alzheimer’s disease with immunotherapy against the β-amyloid (Aβ) peptide or with enzyme inhibitors to reduce Aβ production have not yet resulted in effective treatment, suggesting that alternative strategies may be useful. The gene discussed is PPIB; the disease is early-onset autosomal dominant Alzheimer disease.